Conference Material
|
Slide Presentation
Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis
Gotham D,
Martin M,
Barber M,
Kazounis E,
Batts C,
Scourse R,
Elder G,
Nyang'wa BT
Download
View PDF
Share
No abstract available
Countries
Belarus
South Africa
Subject Area
tuberculosis
Languages
English
DOI
10.57740/asasBXQ
Published Date
16 May 2024
Conference
MSF Scientific Day International 2024
Linked Content
Conference Material
|
Video
Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis
2024 May 16 • MSF Scientific Day International 2024
Similar Content
Video
|
Video
Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis
2024 May 16 • MSF Scientific Day International 2024
Loading...
Loading...
View HTML
View PDF
Share
Download